{"denoms":[{"counts":[{"groupId":"BG000","value":"164"}],"units":"Participants"}],"groups":[{"description":"Busulfan 32 mg/m\\^2 intravenous (IV) for 1 Day then 130 mg/m\\^2 IV for 4 Days; and Melphalan 70 mg/m\\^2 IV for 2 Days","id":"BG000","title":"Busulfan + Melphalan"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"18","upperLimit":"66","value":"42"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"67"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"97"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"164"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}